The role that interleukin-2 (IL-2) plays in T-cell development is not known. To address this issue, we have investigated the nature of the abnormal thymic development and autoimmune disorders that occurs in IL-2-deficient (IL-2-/-) mice. After 4 to 5 weeks of birth, IL-2 -/-mice progressively develop a thymic disorder resulting in the disruption of thymocyte maturation. This disorder is characterized by a dramatic reduction in cellularity, the selective loss of immature CD4-8-(double negative; DN) and CD4+8 (double positive; DP) thymocytes and defects in the thymic stromal-cell compartment. Immunohistochemical staining of sections of thymuses from specific pathogen-free and germ-free IL-2 -/-mice of various ages showed a progressive ,loss of cortical epithelial cells, MHC class II-expressing cells, monocytes, and macrophages. Reduced numbers of macrophages were apparent as early as week after birth.
INTRODUCTION
Thymocyte development is dependent on the intimate association with stromal cells and the cytokine milieu of the thymus (reviewed in Carding and Reya, 1994) . Among the cytokines that are normally produced within the thymus during T-cell development, has been the most intensively studied. The expression of functional by developing thymocytes (Skinner, et al., 1987; Jenkinson et al., 1987; Waanders et al., 1989 Waanders et al., , 1990 , and the ability of anti-IL-2R antibodies to disrupt thymocyte growth and/or proliferation in vivo (Tentori et al., 1988; Tanaka et al., 1992) provide strong evidence for a direct role for IL-2 in thymocyte development. Recent studies analyzing thymocyte development in IL-2-deficient (IL-2-/-) mice have provided more direct evidence for a requirement for IL-2 for normal thymocyte development.
Although the initial analysis of thymocyte development in neonatal IL-2 -/-mice did not detect any changes in the cellularity or composition of thymocytes (Schorle et al., 1991) , these animals subsequently develop a fatal autoimmune disorder characterized by hyperactivation of peripheral T cells, lymphadenopathy, splenomegaly, hemolytic anemia, and colitis (Sadlack et al., 1993; Horak et al., 1995) . Subsequent studies of IL-2 -/-mice bred onto the athymic nu/nu background and RAG-2 -/-mice reconstituted with IL-2 -/-bone marrow have shown that the immunopathology in these mice depends on the intrathymic differentiation of T cells carrying the IL-2 mutation (Krimer et al., 1995) . Other studies identifying phenotypic changes in subsets of thymocytes (Hanke et al., 1994; Lfidvfksson et al., 1997) , or abnormal cytokine production (LfidvNsson et al., 1997) by IL-2 -/-thymocytes also implicate defects in thymic development as the underlying basis of disease pathology in these mice. Finally, our recent finding that IL-2 -/-mice kept in a germ-free environment also develop lymphoid hyperplasia and autoimmunity (Contractor et al., in press) is also consistent with a defect in central and/or peripheral tolerance being responsible for disease rather than an uncontrolled peripheral T-cell response to environmental antigens. Although the evidence in favor of IL-2 being involved and required for thymocyte growth, survival, and/or (Fig. 2) . Since most of these cells also express high levels of CD3, CD44 expression is unlikely in this case to be a marker of immaturity (Godfrey and Zlotnik, 1993) grossly and histologically normal (data not shown). (host) , and 4 to 5 weeks later, the animals were euthanized and the thymuses analyzed for the presence of CD4-, CD8-, and CD3-expressing cells that were Thy 1.2 (donor) or Thy 1.1 (host) using three-color flow cytometric analysis as described in the legend of Fig. 1 (Fig. 4) , being more voluminous and intensely stained. Since the extent of cellular heterogeneity of ER-TR4 cells or the biochemical nature of the antigen(s) recognized by this antibody is not known, the significance of this change in cortical EC morphology and phenotype remains unclear. These changes in the appearance and distribution of thymic cortical EC were first evident between 4 and 5 weeks of age.
The medullary, ER-TR5+, EC in the IL-2 -/-thymi were indistinguishable from those in IL-2 +/+ thymuses, which appeared as dense interwoven networks of large semireticular cells with short cytoplasmic processes (Fig. 4) FIGURE 5 Loss of MHC class II expression and bone-marrow-derived stromal cell elements in the thymus of IL-2 -/-mice. Frozen sections of thymuses from 5-week-old SPF IL-2 +/+ (+/+) and IL-2 -/-(-/-) mice were stained with the anti-macrophage-specific antibodies Mac-1 (A and B) and F4/80 (C and D), and with the anti-thymic dendritic-cell antibody MIDC-8 (E and F) and the anti-MHC class II-specific antibody Y-3P (G and H). Bound antibody was visualized as described in the legend to Fig. 4 (Breel et al., 1987) , in the thymuses of SPF (Fig. 4) with the appearance of other signs of disease (e.g., anemia). Changes in thymic stromal-cell populations were evident at 6 weeks of age (Fig. 7) , and as seen in the thymuses of SPF IL-2 -/-mice, bone-marrowderived macrophages were particularly affected. Cortical epithelial cells were also reduced in number, and the level of MHC class II staining was also reduced compared to that seen in sections of thymuses from germ-free IL-2 +/+ animals (data not shown). In summary, the absence of IL-2 results in the disruption of T-cell development, which appears to be attributable to changes in thymic architecture and deficiencies in specific stromal-cell populations.
DISCUSSION
The fatal immunopathology that develops in IL-2 -/-mice is dependent on the thymic generation of T cells carrying the IL-2 mutation (Krimer et al., 1995) , consistent with many previous studies demonstrating a role for IL-2 in normal thymocyte development (reviewed in Carding and Reya, 1994 are consistent with abnormal microenvironments being responsible for dysfunctional thymocyte development in these animals. Although few reagents are available to analyze thymic stromal cells, our studies suggest that the disruption of thymic microenvironments is attributable to the presence of abnormal populations of cortical stromal cells, a progressive loss of MHC class II expression, and bone-marrow-derived macrophages. Together, these defects would severely compromise T-cell repertoire selection and could account for the presence of autoreactive CD4 T cells and autoimmunity in IL-2 -/-mice. The presence of thymic stromal-cell abnormalities in germ-free mice, in which the appearance of hyperactivated T cells is delayed, suggests that the stromal-cell abnormalities are unlikely to be a consequence of the activity of dysfunctional T cells. The failure to detect any effect of the absence of IL-2 on thymic repertoire selection of a MHC class Irestricted CD8 T cells (Krimer et al., 1994) is not surprising in view of the normal distribution of MHC class I expression in the thymuses of IL-2 -/-mice (Fig. 3) . Yet, the possibility that IL-2/IL-2R signaling is involved in CD4 T-cell repertoire selection cannot be excluded. Our recent finding that thymocytes from ovalbumin-specific, I-A-restricted, TCR-transgenic mice treated with antigen produce IL-2 while undergoing negative selection and the deletion of antigenspecific CD4+CD8 thymocytes in vivo is abrogated in the presence of anti-IL-2R antibodies (Bassiri et It has been proposed that the hematopoietic and immune system disorders that develop in IL-2 -/-mice are caused by lymphoid hyperplasia and T-cell infiltration into various tissues (Krimer et al., 1995; Sadlack et al., 1995) . Although we cannot exclude the possibility that dysfunctional T cells contribute to or exacerbate the thymic defects in these mice, the fact that stromal-cell defects are apparent in neonatal IL-2 -/-mice that have very few peripheral T cells and show no signs of disease makes it unlikely they are the cause of this disorder.
Since the cortical and medullary macrophage populations are initially intact in the thymuses of neonatal (1-to 3-day-old) IL-2 -/-mice, IL-2 may function primarily as a survival factor for these cells. Consistent with such an effect of IL-2 on myeloid cells is its ability to promote the survival in vitro of mature neutrophils (Pericle et al., 1994) . A differential requirement for IL-2 by thymic macrophages during neonatal and adult stages of T-cell development is another attractive possibility in light of other studies demonstrating age-related changes in both the developmental potential of macrophage progenitor populations and the microenvironments in which they develop (Naito, 1993; Naito et al., 1996) . The observation that other bone-marrow-derived stromal cells (dendritic cells) are intact in IL-2 -/-thymuses suggests that the loss of thymic macrophages is not related to stress and the systemic production of corticosteroids. Although the expression of functional IL-2Rs by EC has been described (Weidmann et al., 1992; Ciacci et (Surh et al., 1992; Palmer et al., 1993) and through the production of growth factors (Carding and Reya, 1994) (Schorle, 1991) . Heterozygote sex-matched littermates were used as controls for all experiments using IL-2 -/-animals or cells. The frequency and age of onset of anemia and colitis in homozygous animals maintained in our facility were the same as previously reported (Sadlack et al., 1993 
